Fluid treatment guided by heart response for acute pancreatitis
Treatments studied
Part of Digestive system clinical trials.
This study tests whether giving IV fluids based on how your heart responds can improve recovery from acute pancreatitis, compared with usual care. It may help your body handle fluids better during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with moderate to severe acute pancreatitis within the last 24 hours
- You are not pregnant or incarcerated
- You do not have serious heart, kidney, or liver disease
- You are able to move your legs (for example, do a straight leg raise) without missing a limb
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares standard fluids (Ringer's lactate) to a combination of dextran 40 and Ringer's lactate for treating mild or moderate acute pancreatitis. It aims to see which works better for rehydration and recovery.
This trial tests a special cooling catheter placed in the body to reduce inflammation during severe pancreatitis. It may help patients who are sick enough to need hospital care but have not had pancreatitis before or other major health issues.
This study tests whether heparin, a blood-thinning medication, can help prevent organ damage in people with acute pancreatitis (sudden severe pancreas inflammation). Researchers believe heparin may reduce the risk of serious complications like organ failure.
This trial compares whether patients with mild acute pancreatitis (sudden pancreas inflammation) can safely recover at home with outpatient visits instead of staying in the hospital. The goal is to see if home care is as effective and safe as inpatient care for patients with mild cases.
This trial tests whether an epidural (a numbing shot near the spine) can reduce pain and improve recovery in people with severe pancreatitis who have early problems with their lungs, heart, or kidneys. It is designed for people in the intensive care unit.
This study tests whether giving lactated Ringer’s solution (a specific IV fluid) during an ERCP procedure can lower the chance of developing post-ERCP pancreatitis (painful pancreas inflammation after the procedure). You may be considered if your ERCP has a higher risk of triggering pancreatitis.
Hear when a new Acute Pancreatitis (AP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.